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Hepatitis C: Enhancing Routine
Surveillance in Victoria
Sean Tobin, Communicable Diseases Section, Department of Human Services
sean.tobin@dhs.vic.gov.au
The Department of Human Services is introducing a range of new measures to enhance
hepatitis C surveillance in Victoria.  A review of hepatitis C notifications in Victoria for
the period 1997 to 2000 is presented, followed by an outline of the new enhanced
surveillance activities being undertaken this year.
According to the most current modelling
of hepatitis C virus (HCV) infection in
Australia, an estimated 190 000 people
were living with the infection in 1997.1
Modelling also estimates 11 000 acute
infections each year, with 91 per cent
exposed through injecting drugs.
The most recent national notification data
indicate that there were 21 058 notifications
in 1999, of which 385 (1.8 per cent) were
identified as being acute infections
(Personal communication, J Spencer). HCV
notifications from Victoria represented
approximately 29 per cent of the national
notifications in 1999, with less than one per
cent of infections identified as being acute.
The disparity between HCV incidence
estimates obtained through modelling and
those made from notification data
highlights the gap in our understanding of
the epidemic of HCV infection in
Australia. 
PASSIVE HCV SURVEILLANCE IN
VICTORIA, 1990–2000
HCV was made a notifiable disease in
Victoria in 1990, coinciding with the
availability of commercial assays to test for
HCV infection. All laboratories and
medical practitioners are required to notify
the Department of Human Services of
HCV diagnoses within five days. 
For surveillance purposes, the Department
classifies HCV notifications as ‘acute
hepatitis C’ or ‘hepatitis C, not further
specified’. Acute infections are defined as:
• The demonstration of seroconversion to
HCV where the most recent negative
specimen was within the past 12 months,
or
• The demonstration of a positive HCV
antibody test or a positive polymerase
chain reaction (PCR) test for HCV, and a
clinical illness consistent with acute
hepatitis within the past 12 months
where other possible causes of acute
hepatitis have been excluded.
HCV infections associated with a positive
HCV antibody or PCR test in the absence
of a negative test in the previous 12 months
and with no clinical evidence of an acute
hepatitis illness are classified as ‘hepatitis
C, not further specified’. If a previously
unreported positive HCV antibody or PCR
test is identified, then the case is further
classified as prevalent.
HCV NOTIFICATIONS FOR 1997–2000
During the four-year period 1997–2000, the
Department received a total of 23 619
notifications of hepatitis C infection.
Although the proportion of acute cases has
risen since 1997, acute notifications still
represented less than one per cent of all
notifications in 2000. 
1997 1998 1999 2000 1997–2000  
Hepatitis C—acute 11 54 76 78 219  
Hepatitis C—not 4 977 6 299 6 279 5 845 23 400
further specified 
Hepatitis C—total 4 988 6 353 6 355 5 923 23 619
The Department divides Victoria into four Melbourne
metropolitan regions (Northern, Southern, Eastern and
Western) and five non-metropolitan regions (Barwon
South-West, Gippsland, Grampians, Hume and Loddon
Mallee). Notifications of HCV are more common in
metropolitan regions than in non-metropolitan regions,
with the Southern Metropolitan region contributing the
highest total number of notifications. The Western
Metropolitan region had the highest cumulative
notification rate per 100 000 population for the period
1997–2000 for both males and females (Figure 1). Almost
two thirds (62 per cent) of all hepatitis C notifications in
the four-year period were for males—a proportion that
was consistent for all regions.
In the same four-year period, 219 notifications were
defined as acute infections, or approximately one per cent
of all HCV notifications. Approximately 80 per cent of
acute notifications were of cases in metropolitan regions,
with the highest notification rates also in the Western
Metropolitan region. These findings should be interpreted
with caution, given the small numbers of cases involved.
Focusing on 2000, 67 (86 per cent) acute cases in that year
gave a history of intravenous drug use (either current or in
the past), six cases denied intravenous drug use, and the
risk factor status of five cases was unknown. Two of the
six acute cases who denied a history of intravenous drug
use reported having either nose piercing or tattooing in
the previous 12 months. Infection control investigations
were conducted in two linked premises, nominated by the
two acute cases, that perform tattoos and/or nose
piercing. No infection control deficiencies were identified.
Exposure information is usually ascertained from the
reporting doctor rather than from the patient directly, so
infection was possibly related to unreported risk factors.
Of the remaining four cases who denied a history of
intravenous drug use, one case reported having had
unprotected sexual intercourse overseas in the previous 
12 months and another case was associated with a needle-
stick injury. One case appears to have resulted from
vertical transmission. No risk factor could be identified for
one further case. 
Of the 78 HCV notifications identified as acute infections
in 2000, 57 (73 per cent) were first notified by the testing
laboratory, with the remainder first notified by the treating
doctor. Of the same 78 HCV notifications, 57 (73 per cent)
met the case definition for documented HCV antibody
seroconversion alone, 11 (14 per cent) met the case
definition for a positive HCV antibody or PCR test and a
clinical illness consistent with acute hepatitis alone, and 10
(13 per cent) met both case definitions.
ENHANCED HCV SURVEILLANCE IN 2001
The Department has committed to a national strategy to
improve surveillance of HCV infection. This strategy
recommends establishing routine systematic assessment of
all new hepatitis C diagnoses to identify incident cases,
and developing a standardised protocol for collecting more
detailed data on incident cases.2 The strategy aims to:
• Ensure collection of up-to-date information on the
epidemiology of HCV infection.
• Detect outbreaks of HCV infection.
• Detect novel modes of transmission.
• Identify those at risk to target prevention and control
strategies appropriately.
• Evaluate prevention and control strategies.
The previous passive hepatitis C surveillance system has been
relatively insensitive in detecting acute infections, being
wholly dependent on the notifying doctor or laboratory. As a
result, many acute infections are likely to have been
misclassified as ‘hepatitis C, not further specified’.
Identification of cases who constitute an occupational risk
of transmission or who may have acquired the infection
through nosocomial or novel forms of transmission are
highly dependent on the notifying doctor indicating this
transmission risk.
Although the Depart-
ment’s passive HCV
surveillance strategy has
had some notable achieve-
ments, it has been difficult
to make use of the great
bulk of the surveillance
data, given the problem of
determining the prop-
ortion of notifications that
represent acute infections.
This information is vital to
understanding the chang-
ing epidemiology of the
disease and evaluating
prevention strategies.
A short pilot study cond-
ucted in 2000, involving
intensive follow-up of all
notifications, found that
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Table 1: Hepatitus C Notifications, Victoria, 1997–2000.
Figure 1: Cumulative HCV Notifications, 1997-2000: Notifications and Notification Rates by Department Region.
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approximately four per cent of notifications could be
confirmed as acute infections, compared with less than one
per cent identified through the conventional methods.
Routine follow-up of all of the approximately 6000 HCV
notifications received each year would be extremely
resource intensive and inefficient, so a variety of
alternative strategies are being developed to enhance the
HCV surveillance system. Aimed at improving our
understanding of the routinely collected HCV surveillance
data, these strategies include the following measures.
CONDUCTING RANDOM SAMPLING OF HCV
NOTIFICATIONS FOR INTENSIVE FOLLOW-UP
From February 2001 the Department has undertaken
intensive follow-up of routine HCV notifications by
selecting each week a random sample of 10 per cent of the
weekly notifications. No weighting is given to groups at
higher risk of acute infection, so as to maintain the capacity
to generalise the results to the non-sampled notifications.
To date, six per cent of sampled notifications have been
identified as acute infections, with a further 15 per cent
identified as prevalent infections. The remainder cannot
be classified as either acute or prevalent, given the
available information. 
INCREASING LABORATORY REPORTING OF
PREVIOUS HCV TEST RESULTS
While only a few laboratories report previous HCV test
results, almost half of all HCV notifications identified as
being acute in 2000 (36 of 78) were identified because a
laboratory indicated that they had a record of a previous
negative HCV antibody test in the previous 12 months.
The Department will consult both public and private
laboratories to increase the reporting of previous negative
HCV testing when laboratories notify the Department of a
positive HCV result.
IMPROVING LIAISON WITH ORGANISATIONS
THAT PERFORM SERIAL TESTING
Organisations such as the Red Cross Blood Bank, prisons
and correctional centres, and sexual health clinics perform
repeated HCV testing of clients. The Department will seek
to work more closely with these organisations to use
previous testing results to help classify notifications as
acute or prevalent.
MODIFYING THE ‘NOTIFICATION OF INFECTIOUS
DISEASE’ FORM
Following the introduction of the new Health (Infectious
Diseases) Regulations 2001, the Department will change
the ‘Notification of Infectious Disease’ form used by
doctors and laboratories to include a choice under the
hepatitis C category of ‘acute or ‘non-acute’. The form
offers this option currently for only hepatitis B
notifications.
SUMMARY
The combined applications of these strategies is likely to
increase significantly the utility of the HCV surveillance
data collected to help us understand the epidemiology of
HCV infection in Victoria. The silent nature of many HCV
infections means there is a continuing need to supplement
this enhanced surveillance data with the innovative
research by some research institutions (in Victoria and
other States) of populations at higher risk of HCV infection. 
As we collect better information we paint a more complete
picture of HCV infection in Victoria. This assists the
development of more effective prevention strategies and
allows for more appropriate services for those who carry
the infection and suffer its complications.
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Infectious Diseases News
CHANGES TO THE HEALTH (INFECTIOUS
DISEASES) REGULATIONS
To ensure consistency with the list of nationally notifiable
diseases, the following diseases are now notifiable in
Victoria under the  Health (Infectious Diseases)
Regulations 2001, which came into effect on  16 May 2001:
Japanese Encephalitis, Invasive Pneumococcal Disease,
Influenza (laboratory confirmed), Lyssavirus (Australian
Bat Lyssavirus and other lyssaviruses), Cryptosporidiosis,
Hepatitis D and Hepatitis E. 
Diseases which have been removed from the list are: Primary
amoebic meningo-encephalitis, Typhus, Amoebiasis,
Hydatid Disease, Taeniasis (tape worm infections),
Yersiniosis, Chancroid and Lymphogranuloma venereum.  
The regulations prioritise the notification requirements,
identifying some diseases as group ‘A’ which require
urgent notification upon initial diagnosis (presumptive 
or confirmed) by telephone or facsimile, followed 
by written notification within five days. Written
notification of all diseases should occur within five days of
diagnosis. New notification forms are available at
http://www.dhs.vic.gov.au/phd/0002003/index.htm,
and information sessions for stakeholders will be
conducted in each of the regions. For further information
please contact the Communicable Diseases Section on  (03)
9637 4126. 
SCRATCHING FOR ANSWERS? 
Head lice are an age-old problem—10 000 years old in fact.
After reviewing the often conflicting literature regarding
the control and management of head lice infections
(pediculosis), the Communicable Diseases Section is
undertaking a community-wide head lice education and
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awareness program. Its primary objective is to debunk the
myths regarding the treatment of head lice.
A pamphlet distributed for families contains new
information on how to adopt a head lice management
strategy that is effective, safe and inexpensive. Head lice
treatment has moved in a new direction and much of the
previous information is outdated, unnecessary and
inaccurate. Combing a child’s dry hair once per week with
ordinary hair conditioner will contain the head lice
problem for many households. 
Important changes introduced in the pamphlet include the
use of treatment options other than insecticides. Australian
and international research suggests cleaning or treating
household or classroom environments is unnecessary.
As part of the awareness program the Department of
Human Services has set up a new web site (www.dhs.
vic.gov.au/phd/headlice) about the management and
control of head lice. It provides information for schools,
parents and Local Government.
UPCOMING CONFERENCES
The annual Public Health Association (PHA) Conference
will be held on 23–26 September 2001 in Sydney and the
Australasian Epidemiological Association (AEA)
Conference will be held on 27–28 September 2001 in
Sydney. You can obtain further information and
registration details at the following web sites respectively: 
• http://www.pha.org.au/conferences/frame_conferences
.html (PHA conference)
• http://som.flinders.edu.au/fusa/index.htm 
(AEA conference).
OZFOODNET-ENHANCING FOODBORNE DISEASE
SURVEILLANCE ACROSS AUSTRALIA
The Commonwealth Department of Health and Aged Care
(DHAC) has funded all States to conduct enhanced food-
borne disease surveillance, in a project called
‘OzFoodNet—Enhancing Food-borne Disease Surveillance
Across Australia’. The main aims of OzFoodNet are to
estimate the incidence and burden of food-borne disease in
Australia, and to identify causes, risk factors and
opportunities for disease prevention.
OzFoodNet–Victoria was established in November 2000.
The Communicable Diseases Section of the Department of
Human Services will manage this two-year project, which
Department staff Nittita Prasopa-Plaizier and Joy Gregory
will implement.
The focus of the first three months of the project has been on:
• Establishing the project and setting specific aims and
objectives.
• Networking with stakeholders, (general practitioners,
environmental health officers).
• Cooperating with counterparts in other States.
• Reviewing data on potential food-borne diseases.
• Evaluating existing food-borne disease surveillance
systems. 
The next stage will be the implementation of national and
statewide case control studies for specific diseases,
including salmonellosis, campylobacteriosis and
listeriosis.
You can obtain further information about the project by
contacting Joy Gregory (03 9737 5897; joy.gregory@
dhs.vic.gov.au) or Nittita Prasopa-Plaizier (03 9637 4839;
nittita.prasopa-plaizier@dhs.vic.gov.au).
DNA Fingerprinting Analysis of Australian
Mycobacterium tuberculosis Strains Using
Gelcompar™
Maria Purcell, Lilly Yuen, Kerry Raios, Janet Fyfe, Aina Sievers and Geoff Hogg, Mycobacterium Reference Laboratory, Victorian
Infectious Diseases Reference Laboratory
maria.globan@mh.org.au
Tuberculosis is caused by the bacterium Mycobacterium tuberculosis (M.tb) and developments in molecular technology
have enabled M.tb strains to be DNA fingerprinted.  Through fingerprinting, transmission of strains can be tracked by
comparison of their individual genetic profiles.  Comparison of strains has now become simpler with the use of a
computer software program – Gelcompar. We describe the use of Gelcompar and its value in enhancing our
understanding of the epidemiology of tuberculosis in Australia.
BACKGROUND
Worldwide, tuberculosis is a disease of major public
health concern. The main causative agent of tuberculosis is
Mycobacterium tuberculosis (M. tb), which is a member of
the genus Mycobacterium of the Mycobacteriaceae family.
The incidence of tuberculosis in Australia is relatively low,
with three to four cases notified per 100 000 population
each year. Since the mid-1980s, approximately 700 new
bacteriologically confirmed cases are reported each
year.1,2,3,4 
Since 1991, the Mycobacterium Reference Laboratory
within the Victorian Infectious Diseases Reference
Laboratory (VIDRL) has been performing restriction
fragment length polymorphism (RFLP) analysis on M. tb
strains from around Australia. This project, originally
known as the Australian Tuberculosis Project, was
established to help our understanding of the
epidemiology of tuberculosis within Australia. 
RFLP TYPING OF M. TB STRAINS
The aim of RFLP typing is to produce patterns of DNA
fragments—known as DNA fingerprints of bacteria—
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within the same species so they can be compared. 
RFLP typing involves three main steps:
1. Restriction enzyme digestion of extracted chromosomal
DNA.
2. Electrophoresis of the digested DNA.
3. Southern blot hybridisation using probes to produce a
pattern of bands.
RFLP typing techniques based on the position within the
genome of the mobile insertion sequence IS61105 or a
repetitive element pTBN126 have provided molecular
methods to distinguish strains of M. tb. The insertion
sequence IS6110 is present only in the genome of the M. tb
complex usually between six and fifteen copies; however,
some strains have only a few copies or lack any copies.
These strains do not generate sufficient polymorphism to
be readily distinguished via IS6110 so it is necessary to use
a second probe—pTBN12. 
The cloned repetitive element within the plasmid pTBN12
is distributed within the genome of M. tb as well as other
mycobacterial species such as M.kansasii, M.gastri,
M.szulgai, M.ulcerans and M.gordonae.6 It is present in at
least 30 copies per genome. 
M. tb strains with very similar or identical RFLP patterns
are considered to be genetically related and are then
placed into a cluster.7 Isolates with five or fewer copies of
IS6110 are not grouped into a cluster, because these results
do not provide sufficient discrimination. Typing with
pTBN12 offers more discrimination between such strains
because there are more copies of this element in the
genome.8
COMPARISON OF PROFILES
Following RFLP typing of the M. tb strains, the profiles
generated are compared. Prior to 1998 we had received
approximately 3700 M. tb strains for RFLP analysis. Initial
comparisons were performed by eye. Of these, we
identified 86 different clusters of genetically related strains
of M. tb, including a cluster in homeless men and their
associates (which has been called the Homeless or 
H+ strain).9 We also recognised some M. tb strains of
Vietnamese origin that have no copies of IS6110 within
their genome but do contain the pTBN12 repetitive
element.10 
Currently, we have over 4800 M. tb strains for comparison.
Eye comparison with such a large group of strains is no
longer a feasible option. Thus, we assessed  software that
could perform the comparisons and then subsequently
store the information generated, creating an electronic
database of M. tb RFLP profiles. 
GELCOMPAR™ SOFTWARE PROGRAM
The Gelcompar (Applied Maths, Kortrijk, Belgium)
software program is able to compare electrophoretic
banding patterns and enables patterns to be stored in a
central location. Before Gelcompar is applied, the southern
blots with the chromosomal DNA that has been
electrophoresed to produce a characteristic banding
pattern are scanned with either a flatbed scanner or a
densitometer. The image generated is stored as a TIFF file
(tagged image file format), which Gelcompar can then
analyse. Two important steps prepare the scanned image
for comparison prior to analysis.
1. A conversion program converts and defines each of the
RFLP profiles on the southern blot into individual tracks
that Gelcompar can recognise. 
2. A normalisation program normalises the raw track data
generated from the conversion program. When DNA
samples are electrophoresed to obtain fingerprints,
distortions are observed between and within gels, even
in the most reproducible conditions. Normalisation
compensates for these distortions. An external
molecular weight marker, consisting of a mixture of
both small and large DNA fragments, is placed at
regular intervals on each gel and labelled as a reference
track. To enable comparison of images from different
gels, a standard reference track pattern is pre-defined.
The bands in the reference tracks are stretched or
compressed to match each other relative to the pre-
defined standard, thus enabling the non-reference tracks
to be aligned accordingly at the same time. Because the
reference tracks from every gel are aligned to a standard
reference pattern, all gels are then compatible with each
other. This enables us to generate pattern databases. 
Following conversion and normalisation of the scanned
images, it is then possible to perform profile comparisons
and cluster analysis. Gelcompar offers a number of
different clustering methods for track comparison. We
used a combination of the UPGMA (unweighted pair
group method using arithmetic averages) clustering
algorithm and the Jaccard coefficient. This method of
clustering is more suitable for comparisons based on the
position of the bands within each track. The percentage
similarity calculated between the tracks is then expressed
as a dendrogram. 
Once an RFLP profile has been defined as a Gelcompar
track, and the band positions have been marked, the track
can be compared with all of the existing tracks on the
database. Thus, it is possible to compare an RFLP track
with other profiles collected across Australia or with only
a subset (for example, RFLP types obtained from Victoria
only) of the existing tracks stored. 
RFLP TYPING PROTOCOL
Our current protocol for typing is to type every first M. tb
isolate received (that is, no repeat isolations from the same
patient) with IS6110. All isolates that have a percentage
similarity of greater than 90 per cent with IS6110,11
including those with 100 per cent similarity, are typed
with the secondary pTBN12 probe. In addition, all isolates
with five or fewer copies of IS6110 are re-typed with
pTBN12. This protocol correlates with the typing
procedures currently used overseas.
GELCOMPAR ANALYSIS 
We have been able to further identify 13 clusters of
genetically related strains of M. tb, making a total of 99
clusters determined Australia wide. An extra five
homeless (H+) strains have been added to the list, which
now has 77 cases defined in this cluster (which spans five
Australian states and one Territory). The number of new
clusters is expected to rise as the number of profiles
increases on the RFLP typing database. 
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SUMMARY
It is envisaged that Gelcompar data will be routinely used
to confirm clusters that are suspected epidemiologically or
to detect previously unrecognised potential
epidemiological links. The software may detect significant
profiles in a given ethnic or social population (for example,
the homeless strain) or it may identify specific strains with
unique properties (such as drug resistance). It will also
enable rapid comparison with a given RFLP type, and
allow us to compare strains from different geographic
areas and track the movement of individual strains. Given
that the DNA fingerprints of M. tb strains will be more
readily available, the software’s contribution to our
understanding of the epidemiology of tuberculosis in
Australia will be invaluable. 
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Sequential Transmission of Norwalk Virus at a
Holiday Camp
Heather O’Donnell and Kerry-Ann O’Grady, Communicable Diseases Section, Department of Human Services, and John Marshal,
Victorian Infectious Diseases Reference Laboratory
Heather.O’Donnell@dhs.vic.gov.au
The Communicable Diseases Section of the Department of Human Services was notified on 16 March 2001 of an outbreak
of gastrointestinal illness at a holiday camp. Investigations revealed that seven different groups were affected by
Norwalk-like virus gastroenteritis, over a three-week period. This report summarises the outbreak investigation and
discusses the implications for the control of diseases in these settings.
INTRODUCTION
Norwalk-like virus (NLV) is highly infectious and causes a
usually mild and self-limiting gastroenteritis. Known routes
of transmission include person-to-person contact, ingestion
of contaminated food or water, fomites, aerosols and
exposure to contaminated environments.1 In Victoria,
gastroenteritis outbreaks due to NLV have occurred in a
variety of settings including guesthouses, hospitals, schools,
recreational camps and nursing homes.1 
Little is known about the survival of NLV particles in the
environment or the disinfection procedures necessary to
remove them from contaminated settings.2 Here, we report
consecutive outbreaks of NLV gastroenteritis in a holiday
camp and discuss the implications for controlling disease
in these settings.
BACKGROUND
On 16 March 2001 the Communicable Diseases Section
was notified of an outbreak of gastrointestinal illness at a
holiday camp. A school group (group D) at the campsite
had reported symptoms of vomiting, abdominal cramps
and diarrhoea.
Investigations revealed that three other groups had used the
campsite in the preceding week and all reported participants
with a similar illness. Two were school groups (groups A and
B) and the third was a church group (group C). A fifth group
(group E—a support group for siblings of disabled children)
entered the campsite on the evening of 16 March.
While clean-up procedures as per Department of Human
Services guidelines had been implemented on 16 and 17
March, illness was reported on 26 March in two further
groups (Groups F and G—a school group and a church
group respectively) who had attended the campsite after
the initial interventions.
METHODS
SETTING
The duration of each camp ranged from 2.5 to 3.5 days.
Campers were accommodated in dormitory-style
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bedrooms, with between 4 and 15 beds per room. Camp
staff prepared meals, which were served in a common
dining room. Depending on a group’s length of stay,
128–165 foods were served over 11–14 meals, with similar
menus for all groups. A range of activities was conducted
on site. The facility has two communal bathrooms
consisting of toilets, handbasins and showers.
EPIDEMIOLOGICAL INVESTIGATION
A probable case was defined as a person who had
attended the camp between 5 March and 25 March 2001
and who had had a gastrointestinal illness consisting of
vomiting and/or diarrhoea. Cases were confirmed if NLV
was detected in a faecal specimen.
Cohort studies of students and staff attending the camp from
groups A, B and D were conducted. Staff and students
completed a questionnaire in a classroom setting. Groups C
and E did not complete questionnaires because organisers did
not provide attendance lists; however, information was
collected on the number of attendees who had been ill.
Given that groups F and G were identified later in the
investigation, and that a food source was not suspected,
information on ill persons only was collected for these
groups. This information included the rooms in which
they had been accommodated at the campsite. 
Incubation periods were calculated from the date and time
the groups arrived at the camp to the onset of either
vomiting or diarrhoea.
Local Government Environmental Health Officers
implemented inspection and clean-up procedures at the
camp, including collecting samples and collating operational
information. Faecal and water samples were submitted to the
Microbiological Diagnostic Unit and Victorian Infectious
Diseases Reference Laboratory for analysis. 
RESULTS
DEMOGRAPHIC PROFILE AND ILLNESS
HISTORIES
The available demographic and illness profiles for all
seven groups are outlined in Table 1. No cases were
hospitalised or died.
All groups had had a similar pattern of illness, with a median
incubation period of approximately 48 hours after exposure at
the campsite. Some participants from groups A, B, D and E
reported that either they or family members had been ill
before the camp. Two students from group A had been ill on
the evening they arrived at the camp and one had been ill the
previous day. Additional information collected by Local
Government Environmental Health Officers indicated that
the staff at the campsite had also been ill with gastroenteritis
symptoms in the week that the first groups attended.
Analysis of food and activity histories revealed no
association with illness in any group. 
ENVIRONMENTAL INVESTIGATION
The premises was instructed to undergo a supervised
clean-up on 16 March as per the Department of Human
Services Guidelines for the Investigation of
Gastrointestinal Illness. No leftover food samples were
obtained. Six water samples from various locations
around the camp were submitted for analysis. 
After the initial clean-up it was revealed that the carpeted
areas within the campsite had been cleaned with only hot
soapy water because chemicals bleach carpet. Vomiting
was reported to have occurred in at least two of the
carpeted dormitories, with one being used as a sick room
to house ill camp attendees before sending them home.
Three of the ill persons in groups F and G had been
accommodated in these ‘sick rooms’. All carpets within
the premises were subsequently steam-cleaned, as this is
the only suitable cleaning method for carpets
contaminated by viral particles.2
LABORATORY INVESTIGATIONS
Water samples collected from the camp were found to be
of potable quality and no bacterial pathogens were
isolated. A total of 15 stool specimens (from groups D, F
and G) were submitted for analysis. Twelve specimens
were positive for NLV by reverse transcriptase multiplex
polymerase chain reaction (RT–PCR), three of which were
also positive by electron microscopy. Of these positive
Table 1: Demographic and Illness Profiles of Seven Camp Groups 
Group A Group B Group C Group D Group E Group F Group G  
Camp dates 5–7 March 7–9 March 9–12 March 13–16 March 16–18 March 21–23 March 23–25 March  
Total attendees 88 88 92 68 12 28 39  
Ill attendees 19 48 ?20 35 2 5 4  
Attack rate 22% 55% 21% 51% 17% 18% 10%  
Vomiting 68% 85% – 87% 100% 100% 100%  
Diarrhoea 42% 50% – 63% – 60% 75%  
Abdominal pain 74% 63% – 71% – 40% 75%  
NLV detected – – – 6 – 3 3  
Median age 13 (12–14) 13 (12–45) – 12 (11–13) – 10  11 (11–17)  
Median incubation period (hours) 36 (4–120) 56 (4–84) Approx.  48 (32–144) – Approx. Approx. 
48 hours 48 hours 48 hours  
Median duration of illness (days) 2.5 (1–6) 2 (1–6) – 2 (1–5) – 1 (1–3) 1 (1–2)  
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specimens, six were from group D and three each from
groups F and G. No bacterial pathogens were isolated.
Sequencing of a 342 nucleotide segment in Open Frame 1
of the genome found that 11 of the sequences were
identical. The strain identified shows 94 per cent
nucleotide identity of the Mexico strain of NLV (a less
common strain in Victoria). This suggests that one virus
had been introduced to the camp, stayed there and
infected all groups from which faecal samples were
collected. One faecal sample did not test positive for NLV
until after the sequencing had been conducted.
DISCUSSION
This investigation indicated that NLV gastroenteritis had
affected seven different groups at a holiday camp over a
three-week period. It is likely this was a result of widely
contaminated and inadequately cleaned environments,
particularly carpeted areas. While NLV was only detected
in 12 faecal samples from three of the groups, the
consistent pattern of illness among groups suggests the
same pathogen affected all groups. This is supported by
the identical sequences for 11 NLV samples, the known
stability and infectivity of NLV, and the known use of
dormitory rooms as ‘sick rooms’ where vomiting had
occurred. 
NLVs are  stable, virulent viruses, which can persist in the
environment for prolonged periods. Routine cleaning
procedures such as warm soapy water and vaccuuming
do not destroy these viruses.3 Rather, killing the pathogens
requires a high concentration of chlorine (1000 ppm
freshly constituted granular hypochlorite or 5000 ppm
pre-reconstituted hypochlorite solution) or high
temperatures.2 The Norwalk virus surrogate feline
calicivirus (FCV) is known to survive in the dry state for
21–28 days at room temperature.2
This investigation highlights the need to implement
vigilant clean-up measures and protocols during an
outbreak investigation. It demonstrates that carpets
represent a hazard, because they are able to harbour viable
virus particles for an extended period.3 Importantly, all
areas within premises should be adequately assessed for
the most appropriate methods of cleaning and the
practicalities of application. Alternative mechanisms need
to be implemented if areas are unable to be cleaned with
traditional chemical methods. Attack rates for the latter
groups at the campsite (groups F and G) were significantly
lower than for the earlier groups, which suggests that
contamination within the campsite was present but
probably limited to specific areas.
CONCLUSION
This outbreak supports evidence that reservoirs of
infectious virus in closed settings can result in prolonged
or recurring outbreaks.1,4 It identified the need to establish
more detailed guidelines to remove NLV particles from a
contaminated setting. In particular, we have identified the
need for more specific clean-up guidelines for settings
such as holiday camps, where multiple opportunities exist
for the transmission of viral and bacterial pathogens, and
subsequent outbreaks of disease.
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Immunisation Update
Stephen Pellissier, Prevention and Child Health Section, Department of Human Services
stephen.pellissier@dhs.vic.gov.au
Data cited in this report are based on the Australian Childhood Immunisation Register (ACIR) Coverage Report. The
ACIR report measured immunisation coverage at 31 March 2001 for children who were aged 12–<15 months and for
children aged 24–<27 months at 31 December 2000. Only vaccines administered before 12 months of age were included in
the coverage calculation for the former age group and only those vaccines administered before 24 months of age were
included in the coverage calculation for the latter age group.
Table 1 groups immunisation coverage by Local Government
Area for the two birth cohorts. For a copy of the ACIR report
listing immunisation coverage against individual vaccines,
contact Michele Sands (michele.sands@dhs.vic.gov.au).
Congratulations to all immunisation providers in the
municipalities that achieved coverage of 95 per cent or
higher for children at 12 months of age. Ararat, Moira,
Northern Grampians and Yarriambiack achieved coverage
of over 95 per cent for children at 24 months of age.
No areas had coverage below 80 per cent for children at 12
months of age. Overall, coverage in Victoria of children at 12
months of age was 92 per cent over the three-month period.
Coverage of children aged 24 months remained stable at 85 per
cent. Measles–mumps–rubella (MMR) coverage was 93 per cent.
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Table 1: Childhood Immunisation Coverage, by Local Government Area (LGA)—Victoria, 2001
Age Group % Fully Local Government Area (LGA) Total LGAs 
Immunised (% LGAs)  
12-<15 95%+ Ararat (RC), Central Goldfields (S), Colac-Otway (S), Glenelg (S), Indigo (S), Loddon (S), 15 (19%)  
months Macedon Ranges (S), Melton (S), Murrindindi (S), Northern Grampians (S), South Gippsland (S), 
Southern Grampians (S), Whittlesea (C), Wodonga (RC),  Yarriambiack (S) 
90-94% Ballarat (C), Banyule (C), Bass Coast (S), Baw Baw (S), Bayside (C), Brimbank (C), Buloke (S), 44 (56%)
Campaspe (S), Cardinia (S), Casey (C), Corangamite (S), Darebin (C), Delatite (S), Gannawarra (S), 
Glen Eira (C), Golden Plains (S), Greater Dandenong (C), Greater Geelong (C), Greater Shepparton (C), 
Hobsons Bay (C), Horsham (RC), Hume (C), Knox (C), La Trobe (S), Maribyrnong (C), Maroondah (C), 
Mildura (RC), Mitchell (S), Moira (S), Moonee Valley (C), Moorabool (S), Moreland (C), 
Mount Alexander (S), Moyne (S), Nillumbik (S), Stonnington (C), Strathbogie (S), Surf Coast (S), 
Swan Hill (RC), Warrnambool (C), Whitehorse (C), Wyndham (C), Yarra (C), Yarra Ranges (S) 
85-89% Alpine (S), Boroondara (C), East Gippsland (S), Frankston (C), Greater Bendigo (C), Hindmarsh (S), 16 (21%)
Kingston (C), Manningham (C), Melbourne (C), Monash (C), Mornington Peninsula (S), Pyrenees (S), 
Queenscliffe (B), Wangaratta (RC), Wellington (S), West Wimmera (S) 
80-84% Hepburn (S), Port Phillip (C), Towong (S) 3 (4%)  
<80% Nil 
24-<27 95%+ Ararat (RC), Moira (S), Northern Grampians (S), Yarriambiack (S) 4 (5%)  
months 
90-94% Alpine (S), Campaspe (S), Corangamite (S), Delatite (S), Hindmarsh (S), Indigo (S), Moorabool (S), 10 (13%)
Pyrenees (S), Towong (S), Wangaratta (RC) 
85-89% Ballarat (C), Banyule (C), Bass Coast (S), Baw Baw (S), Casey (S), Colac-Otway (S), East Gippsland (S), 37 (47%)
Frankston (C), Glenelg (S), Golden Plains (S), Greater Bendigo (C), Greater Geelong (C), Greater Shepparton (C), 
Hepburn (S), Horsham (RC), Kingston (C), Knox (C), Macedon Ranges (S), Maroondah (C), Melton (S), Mildura (RC),
Mitchell (S), Moonee Valley (C), Mornington Peninsula (S), Moyne (S), Nillumbik (S), Southern Grampians (S), 
Strathbogie (S), Surf Coast (S), Swan Hill (RC), Warrnambool (C), Wellington (S), Whitehorse (C), Whittlesea (C), 
Wodonga (RC), Wyndham (C), Yarra (C)
80-84% Bayside (C), Boroondara (C), Brimbank (C), Buloke (S), Cardinia (S), Darebin (C), Gannawarra (S), 18 (23%)
Glen Eira (C), Greater Dandenong (C), Hobsons Bay (C), Hume (C), La Trobe (S), Loddon (S), 
Melbourne (C), Moreland (C), Murrindindi (S), Stonnington (C), Yarra Ranges (S)
<80% Central Goldfields (S), Manningham (C), Maribyrnong (C), Monash (C), Mount Alexander (S), 9 (12%)
Port Phillip (C), Queenscliffe (B), South Gippsland (S), West Wimmera (S) 
State/Territory/National (% Fully Immunised)  
12-<15 Australian Capital Territory, Tasmania (93%); Victoria (92%); Queensland, South Australia, New South Wales, 
months  Australia (91%); Western Australia (90%); Northern Territory (89%).   
24-<27 Tasmania (90%); Australian Capital Territory, Queensland, South Australia (88%);  Victoria, Australia (85%);  
months  Western Australia, New South Wales (83%);  Northern Territory (79%).   
Surveillance Report
The Department of Human Services receives notifications of infectious diseases from medical practitioners and
laboratories. These notifications prompt investigation and action to control infectious diseases in Victoria. For some
diseases, investigation is initiated on the basis of clinical suspicion in the absence of laboratory confirmation. Prompt
notification of infectious diseases is an integral component of prompt public health action. Please do not delay. To
notify, call 1300 65 1160 or fax 1300 65 1170.
This section includes a summary of infectious disease notifications received until 31 March 2001. The report has been
produced by the Communicable Diseases Section, Department of Human Services, in cooperation with the Victorian
Infectious Diseases Reference Laboratory and the Epidemiology and Social Research Unit of the Macfarlane Burnet Centre
for Medical Research. We gratefully acknowledge the contribution of the Microbiological Diagnostic Unit, University of
Melbourne; the Melbourne Sexual Health Centre; and the Victorian Collaborative Group on HIV and AIDS Surveillance.
Table 11 includes historical comparisons of selected diseases with 2000 data at both the State and regional level.
Summary data at local government level for the diseases listed in table 4 are available from Greg Mathews,
Communicable Diseases Section, Department of Human Services (03 9637 4108). There have been no notifications of
anthrax, Australian arbo encephalitis, diphtheria, leprosy, plague, poliomyelitis, rabies, primary amoebic meningo-
encephalitis, viral haemorrhagic fevers, yellow fever, tetanus, hepatitus D or hepatitus E.
For comments or queries related to data for sexually transmissible diseases contact Jane Hocking or Dr Nick Crofts,
Epidemiology and Social Research Unit, Macfarlane Burnet Centre for Medical Research (03 9282 2290) or the
Communicable Diseases Section, Department of Human Services (03 9637 4126).
Fortnightly surveillance data from the Victorian Infectious Diseases Reference Laboratory are available at
http://www.dhs.vic.gov.au/vidrl/. All data in this report are provisional and subject to revision as further information
becomes available. You can find general information related to the control of infectious diseases (The Blue Book) online
at http://www.dhs.vic.gov.au/phd/hprot/inf_dis/bluebook/index.htm.
26 Victorian Infectious Diseases Bulletin Volume 4  Issue 2  June 2001
OUTBREAKS OF GASTROINTESTINAL ILLNESS
For the first quarter of 2001, 26 outbreaks of
gastrointestinal illness were reported to the Department’s
Communicable Diseases Section (Table 1).
Table 1: Outbreaks of Gastrointestinal Illness, 1 January – 31 March 2001
Setting Outbreaks Persons Pathogen/Toxin 
Affected (Number of Outbreaks)  
Restaurant/reception/ 10 160 Salmonella (1)
other food premises/ Norwalk virus (4)
specific food  Ciguatera (1)
Unknown (4)  
Aged/disability/health 
care institution 11 196 Norwalk virus (4)
Suspected viral (6)
Results pending (1)  
Recreation/holiday/ 3 136 Cryptosporidiosis (1)
camp Norwalk virus (2)  
Children’s service/school 2 15 Unknown (2)  
TOTAL 26 505 Norwalk virus (10)
Suspected viral (6)
Ciguatera (1)
Salmonella (1)
Cryptosporidiosis (1)
Unknown (6)
Results pending (1)  
A CHRISTENING FUNCTION
A Local Government Environmental Health Officer
reported an outbreak of gastroenteritis among 159 guests
who had attended a Christening function at a restaurant.
Given the size of the cohort, a random sample only of 72
guests were interviewed to facilitate timely identification
of possible sources of the illness. Sixty-two (86 per cent)
interviews were completed. The attack rate in the study
cohort was 52 per cent (95 per cent CI 39–63). Of the 49
faecal specimens collected, 31 (63 per cent) tested positive
for Norwalk-like virus. 
Forty-two different foods had been served buffet style on
platters. The risk of illness was marginally higher for those
who ate the smoked sausages (RR 1.95, 95 per cent CI
1.01–3.79, p=0.05). No association with any other foods
was identified. No bacterial pathogens were isolated in
any foods sampled from the restaurant. 
Dips and food served on platters present a high risk for the
transmission of viral pathogens because they provide an
opportunity for a guest to contaminate food. Food
contaminated by an infectious person was the likely mode
of transmission in this outbreak and would account for the
attack rate of 41 per cent among attendees. Viral pathogens
such as Norwalk-like virus are virulent and have a low
infectious dose. Two people were reported to have been ill
with diarrhoea before attending the function and one
infant had vomited during the evening.
A second outbreak at the same premises was reported in
guests who had attended another Christening function
one week later. Twenty-four of 56 guests were reported ill
with gastroenteritis after attending the function. It was not
possible to obtain a guest list for interviews; however,
three faecal specimens were obtained and Norwalk-like
virus was isolated. The menu for this function was the
same as that for the earlier Christening. After this
outbreak, the premises voluntarily closed for two days for
thorough cleaning and sanitising.
The Victorian Infectious Diseases Reference Laboratory
conducted sequencing analysis on the Norwalk-like virus
specimens collected from these two outbreaks to
determine whether they were identical. Although the two
outbreaks were only a week apart, the sequencing data
indicated that a slightly different variant of the
Camberwell strain of Norwalk-like virus was involved in
each outbreak, suggesting the two events were not related.
CORAL TROUT AND CIGUATERA POISONING
A Local Government Environmental Health Officer
reported an outbreak of ciguatera fish poisoning in 17
people who had consumed a 12-kilogram coral trout
purchased from a local fresh fish shop. The cases
developed symptoms consistent with ciguatera fish
poisoning two hours after consuming the fish. The family,
not knowing that the symptoms were related to
consumption of the fish, continued to consume the
leftovers over the next four days. All of the twelve people
interviewed had a consistent illness history. The fish had
been cooked in soup and the head had also been
consumed. Advice on ciguatera poisoning was given to
local fish shop proprietors.
BOTULISM
One case of infant botulism in a 5-month-old child was
reported during the quarter. Prior to admission, the child
had had a three-day history of poor feeding, constipation,
ptosis, difficulty in swallowing, loss of head control and
weakness. She was admitted to intensive care and spent a
total of 33 days in hospital. 
The infant was breast fed and had tried solid foods on only
a few occasions in the month before the onset of illness—
namely, rice cereal, mashed potato, mashed avocado and
commercially made fruit gel. The child regularly had a
dummy and had had boiled water on a few occasions.
There were various possible exposures, including dust
ingestion. A sample of rice cereal obtained from the child’s
house was negative for Clostridium botulinum spores. No
source for this child’s illness could be determined.
LEGIONELLOSIS
The Department was notified of 36 confirmed cases and
one possible case of legionellosis in Victoria between
January and March 2001. Thirty of these cases (83 per cent)
were male. One case was an overseas visitor who had
acquired his infection in Melbourne. Three live and work
in nonmetropolitan areas, while 32 (89 per cent) live and
work in metropolitan Melbourne.
Of the 36 confirmed cases, one was  Legionella longbeachae,
32 (89 per cent) were Legionella pneumophila 1  and the
remaining three were ungrouped. Diagnosis was
confirmed by culture in five (14 per cent) cases, by
seroconversion in five (14 per cent) cases, and by urinary
antigen in 31 (86 per cent) cases. Five cases were confirmed
by multiple methods: one seroconversion to 
L. pneumophila 1 and four L. pneumophila 1 culture-positive
cases were first identified by urinary antigen. Two culture
positive cases were confirmed as PFGE pattern 1:2 and two
were confirmed as 15:97, which is a strain not previously
identified in Victoria. 
During January–March, there were two outbreaks in the
Melbourne central business district. Two confirmed cases,
who survived, were people working at the same premises,
one of whom was culture positive. The two cooling towers
at the site were sampled and disinfected. Both cooling
towers were positive for L. pneumophila 1. 
The second outbreak involved five people (including two
who died) who worked or visited the same area of the city
during their incubation times. Two cases were culture
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positive, yielding the new PFGE pattern strain. All cooling
towers within a defined area were sampled and
disinfected over a two-day period. 
MEASLES 
Between 1 January and 31 March 2001, 55 cases of measles
were notified to the Communicable Diseases Section. Fifty-
one cases were identified in an outbreak (50 laboratory
confirmed and one epidemiologically linked to a
laboratory-confirmed case), of which 26 were PCR positive
for a novel measles genotype. One additional laboratory-
confirmed case acquired infection while on holidays in the
United States. (In this case, genotyping confirmed that
infection was due to a different strain from that in the
outbreak cases.) Three cases had a clinically compatible
illness but no epidemiological links to other cases. 
The first case was notified on 1 February 2001 and two
more cases were reported the following day. All three were
young adults who had been admitted to hospital. The age
of cases ranged from 10 months to 34 years, with 46 (90 per
cent) aged 15–34 years. Twenty-seven cases (53 per cent)
were male. Twenty-two cases (43 per cent)—all over 15
years of age—were hospitalised. Four cases (all over 15
years of age) had a documented history of measles
vaccination, each having had received a single dose at
approximately 12 months of age. 
The index case was a 19-year-old male (New South Wales
resident) who had recently returned from India and had
spent four days in Melbourne during his infectious period.
During this time he visited restaurants, nightclubs and
shopping centres, and travelled on trams and trains. Direct
links to this person were identified for eight cases and
probable links were identified for a further nine. There
appeared to be four waves of transmission, with
epidemiological links established between 37 cases. Rash
onset in the last case was 12 March 2001.
Control measures included: the isolation of infectious cases
and their unimmunised contacts; identification of and
prophylaxis for susceptible contacts; providing
recommendations regarding who should be vaccinated; a
media release to inform the public and encourage vaccination;
and communications with hospitals and doctors to be alert for
the disease and to notify promptly on clinical suspicion. 
CRYPTOSPORIDIOSIS
Cryptosporidiosis is an acute enteric infection caused by
the parasite Cryptosporidium. Until 16 May 2001,
surveillance for cryptosporidiosis was via a voluntary
laboratory-based reporting scheme. Cryptosporidiosis has
recently been added to the list of notifiable diseases in the
Health (Infectious Diseases) Regulations 2001.
From 1 January to 31 March 2001, the Department received
119 notifications of cryptosporidiosis, compared with 29
for the same time period in 2000. One hundred of these (84
per cent) were for metropolitan Melbourne residents. 
Illness history and exposure information was obtained for 84
cases. Onset of illness in these cases was from early
December 2000, peaking in early March. Sixty-nine cases (82
per cent) reported exposure to public swimming pools in the
two weeks before the onset of their illness, some of whom
continued to swim while they were infectious. Of those cases
who had had no exposure to pools, five reported other risk
factors for illness, including travel, contact with pets and
farm animals, and family members who had been ill.
The high proportion of cases who had been exposed to
public swimming pools suggested a community-wide
outbreak of disease, facilitated by a hot summer and
increases in pool use. Control measures included:
circulating a media release; advising cases about personal
hygiene and avoiding swimming while they have
diarrhoea; informing doctors and laboratories of the
outbreak; and advising pools with two or more linked
cases about how to minimise the risk of further
transmission of disease.
The Communicable Diseases Section would like to thank
the Cooperative Research Centre for Water Quality and
Treatment for their assistance with this investigation.
SEXUALLY TRANSMISSIBLE DISEASES
ACQUIRED IMMUNE DEFICIENCY SYNDROME
(AIDS)
There were 19 cases of AIDS notified during the first
quarter of 2001—18 males and one female. Sixty-three per
cent of cases were men who reported male-to-male sexual
contact. Only three individuals were diagnosed with AIDS
during this quarter.
Although 80 individuals were notified with AIDS during
the 12 months from April 2000 to March 2001 (75 males,
four females and one transgender individual), only 40 (50
per cent) had been diagnosed with AIDS within this period.
The remainder had been diagnosed before April 2000. 
From 1983 to the end of March 2001, 1889 people were
notified with AIDS—1805 males, 76 females and eight
transgender individuals. Over 85 per cent of all males
notified reported male-to-male sexual contact.
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Table 2: Notifications of AIDS in Victoria, January–March 2001, April 2000–March 2001 and Cumulative Total (1983–March 2001)
Jan 2001 – Mar 2001 Apr 2000 – Mar 2001 Cumulative Total to Mar 2001
Male Female Male Female Male Female Total*
Male homosexual/bisexual 12 – 54 – 1539 – 1544  
Male homosexual/bisexual 2 – 3 – 98 – 101
and injecting drug user 
Injecting drug user 0 1 2 1 22 12 34  
Heterosexual 1 0 3 2 60 48 108  
Person from specified country* 0 0 3 1 15 7 22  
Haemophilia/related disorder 0 0 3 0 39 1 40  
Transfusion recipient 0 0 0 0 8 5 13  
Other 0 0 0 0 1 1 2  
Unavailable 3 0 7 0 23 2 25  
Total 18 1 75 4 1805 76 1889  
# Includes eight persons for whom sex was reported as transgender.
* Persons from countries with a high prevalence (>1%) of HIV.
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Table 4: Notifications of HIV in Victoria, by Age Group, January–March 2001, April 2000–March 2001 and Cumulative Total (1983–March 2001)
Age Group Jan 2001 – Mar 2001 Apr 2000 – Mar 2001 Cumulative Total to Mar 2001
Male Female Male Female Male Female Total#
0–12 0 0 0 0 34 10 44  
13–19 0 0 3 0 105 11 117  
20–29 8 3 46 11 1506 103 1624  
30–39 20 0 69 7 1481 63 1552  
40–49 14 2 38 2 638 27 667  
50+ 2 0 19 1 316 24 341  
Unavailable 0 0 0 0 101 1 117  
Total 44 5 175 21 4181 239 4462  
# Includes 16 persons for whom sex was reported as transgender and 26 persons for whom sex was not specified.
Six deaths following either an HIV or AIDS diagnosis were
notified during the first quarter of 2001—five males and
one female. Over the previous 12 months, 40 deaths were
notified, leading to a total of 1582 deaths recorded since
1983. Of these 1582 individuals, 1441(91 per cent) had been
previously diagnosed with AIDS.
Table 3: Notifications of Deaths Following HIV/AIDS Diagnosis in Victoria, January–March 2001, April 2000–March 2001 and Cumulative Total
(1983–March 2001)
Jan 2001 – Mar 2001 Apr 2000 – Mar 2001 Cumulative Total to Mar 2001
Male Female Male Female Male Female Total*
Male homosexual/bisexual 4 – 27 – 1286 – 1291  
Male homosexual/bisexual 1 – 1 – 87 – 90 
and injecting drug user 
Injecting drug user 0 1 2 2 22 9 31  
Heterosexual 0 0 1 0 34 39 73  
Person from specified country* 0 0 1 0 7 3 10  
Haemophilia/related disorder 0 0 2 0 39 1 40  
Transfusion recipient 0 0 0 0 7 5 12  
Other 0 0 0 0 0 1 1  
Unavailable 0 0 4 0 28 2 34  
Total 5 1 38 2 1510 60 1582  
# Includes eight persons for whom sex was reported as transgender and four persons for whom gender was not specified.
* Persons from countries with a high prevalence (>1%) of HIV.
HUMAN IMMUNODEFICIENCY VIRUS (HIV)
INFECTION
Fifty new HIV diagnoses were notified during the first quarter
of 2001 (44 males, five females and one transgender
individual), compared with 51 notified during the same
quarter in 2000. The average age of those notified was 37 years
(range: 22–57 years), with males being older on average (37
years compared with 32 years for females). Eighty-two per
cent of notified males reported male-to-male sexual contact. 
During the 12 months from April 2000 to March 2001,
there were 197 HIV notifications in Victoria: 175 (89 per
cent) males, 21 (10 per cent) females and one transgender
individual. This number is consistent with the 198
notifications reported for the previous 12 months.
Table 5: Notifications of HIV in Victoria, by Exposure Category, January–March 2001, April 2000–March 2001 and Cumulative Total (1983–March 2001)
Exposure Category Jan 2001 – Mar 2001 Apr 2000 – Mar 2001 Cumulative Total to Mar 2001
Male Female Male Female Male Female Total*
Male homosexual/bisexual 36 – 131 – 3398 – 3412  
Male homosexual/bisexual 2 – 9 – 201 – 204
and injecting drug user 
Injecting drug user 0 0 6 1 116 36 155  
Heterosexual 3 4 13 10 168 139 307  
Person from specified country* 2 1 9 10 69 37 106  
Haemophilia/related disorder 0 0 0 0 100 1 101  
Transfusion recipient 0 0 0 0 20 15 35  
Other 0 0 0 0 4 9 13  
Unavailable 1 0 7 0 105 2 129  
Total 44 5 175 21 4181 239 4462  
# Includes 16 persons for whom sex was reported as transgender and 26 persons for whom sex was not specified.
* Persons from countries with a high prevalence (>1%) of HIV.
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Those with newly acquired HIV or incident infection
provide a picture of who is presently affected by the HIV
epidemic. Such individuals are identified on the basis of a
previous negative HIV test and/or a seroconversion
illness within the 12 months preceding HIV diagnosis.
Twenty individuals were notified with incident HIV
infection during the first quarter of 2001—19 males and
one female. During the previous 12 months, 66 individuals
fulfilled the criteria of incident infection. These numbers
are consistent with the 62 individuals reported with
incident HIV infection during 2000. 
Table 6: Notifications of HIV in Victoria, by Time since Last Negative Test or Seroconversion Illness, January–March 2001 and April 2000–March 2001
Time between HIV Diagnosis and Cases Diagnosed Jan 2001 –Mar 2001 Cases Diagnosed Apr 2000– Mar 2001   
Negative Test and/or 
Seroconversion Illness Male Female Total# Male Female Total#  
Less than 1 year 19 1 20 62 4 66  
1 year to less than 3 years 8 0 8 23 3 26  
3 or more years 4 1 6 31 2 34  
No previous negative test 
or seroconversion illness 13 3 16 59 12 71  
Total 44 5 50 175 21 197  
* Includes one person for whom sex was reported as transgender.
CHLAMYDIA INFECTIONS
The Department was notified of 960 cases of Chlamydia
trachomatis in the first quarter of 2001, which was a 23 per
cent increase from the previous quarter’s total of 781 and
a 17 per cent increase from the total (n=819) for the same
period in 2000. The age and sex distribution of cases
remained unchanged, with most cases occurring in young
people aged 20–29 years. 
Table 7: C. trachomatis Notifications in Victoria, by Age and Sex, January–March 2001 and Cumulative Total for April 2000–March 2001
Age Group Jan 2001–Mar 2001 Apr 2000–Mar 2001   
Male Female Unknown Total Male Female Unknown Total  
0–12 years 5 6 0 11 9 18 0 27  
13–19 years 21 102 0 123 66 371 1 438  
20–29 years 207 322 2 531 722 1206 11 1939  
30–39 years 119 93 2 214 424 299 4 727  
40–49 years 29 25 0 54 143 76 1 220  
50+ years 17 9 0 26 59 22 0 81  
Unavailable 0 1 0 1 1 1 1 3  
Total 398 558 4 960 1424 1993 18 3435  
GONORRHOEA INFECTIONS
During the first quarter of 2001, 189 cases of gonorrhoea were
notified. 193 were confirmed by culture and 14 by
polymerase chain reaction (PCR)-based detections of N.
gonorrhoea. A small proportion of cases were diagnosed from
positive samples from more than one site or by more than
one method.
Quarterly gonorrhoea notifications remained at the high
level that has continued since the increase in early 1998.
Men aged 20–49 years comprised 85 per cent of all cases.
Compared with the last quarter of 2000, in the first quarter
of 2001 there was a slight increase in cases among
heterosexual men and a slight decrease among
homosexual and bisexual men. The most commonly
reported source of infection was a local casual sexual
partner (data not shown).
Table 9: Notifications of Gonorrhoea, by Age Group, Victoria,
January–March 2001
Age Group Male Female Total  (%) 
0–12 years 0 1 1 1  
13–19 years 9 2 11 6  
20–29 years 68 4 72 38  
30–39 years 65 3 68 36  
40–49 years 27 2 29 15  
50+ years 8 0 8 4  
Unknown 0 0 0 0  
Total 177 12 189 100   
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Table 8: Notifications of Gonorrhoea, by Sexual Orientation and Sex, Victoria, January–March 2001
Site of infection    
Urethral Vaginal Cervical Rectal Pharyngeal Urine (PCR) Other* Total  
Heterosexual Male 61   0 0 1  62   
Female 0 3 3 0 1 1  8  
Homosexual/bisexual Male 63   14 10 0  87   
Female 0 0 0 0 0 2  2  
Not known Male 17   1 0 6 2  24   
Female 0 3 1 0 0 0  4   
Total 141 6 4 15 11 10 2 189  
* Other (blood, eye).
SYPHILIS INFECTIONS
There were 57 notifications of syphilis in the first quarter of
2001—three of which were reported as infectious syphilis. All
infectious cases were aged 41–45 years and two were male.
TUBERCULOSIS 
The Mycobacterium Reference Laboratory at the Victorian
Infectious Diseases Reference Laboratory prepared this
report. Given the slow-growing nature of Mycobacterium spp,
the report is limited to the fourth quarter of 2000. Most
specimens (both primary and referred) and isolates are from
Victorian patients. The majority of non-Victorian specimens
originate in the Northern Territory and the Solomon Islands.
COMMENTS
• M. kansasii was isolated from sputum specimens from
two males aged 64 years and 78 years and from a 68-
year-old female.
• M. xenopi was isolated from the bronchial washings of a
66-year-old male.
• M. ulcerans was isolated from a leg ulcer of a 22-year-old
male residing in the Melbourne area.
• M. haemophilum was isolated from the blood and skin of
a 75-year-old female.
Table 10: Specimens Submitted to the Mycobacterium Reference Laboratory, by Month, October–December 2000
Primary Specimens M. tb Isolates New Victorian M. tb Isolates Non M. tb isolates Negatives Total
October 21 4 6 438 465  
November 13 7 12 379 404  
December 12 7 14 363 389  
Referred Specimens M. tb Isolates New Victorian M. tb Isolates Non M. tb isolates Total
October 29 15 34  63  
November 39 14 52  91  
December 27 19 40  67  
Total 141 66 158 1180 1479  
Figure 2: New M. tuberculosis Isolates from Victorian Residents, by Age
and Gender,  October–December 2000
Table 11: Extra-pulmonary M. tuberculosis Isolates and Resistant
Isolates, by Month, October–December 2000
October November December  
Pulmonary site 15 13 16  
Extrapulmonary site 4 8 10  
Extrapulmonary 
site details Lymph node (3) Lymph node (4) Lymph node (5)
Arm abscess (1) Retroperitoneal Chest wall bx (1)
abscess (1) Psoas abscess (1)
Neck aspirate (1) CSF (1)
Skin biopsy (1) Neck swab (1)
Small bowel (1) Pelvic mass (1)  
Resistance Resistance to — Resistance to 
Isoniazid and Rifampicin and 
Streptomycin (2) Rifabutol (1); 
resistance to 
Isoniazid, 
Streptomycin and 
Ethambutol (1)  
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summary data on notifications of invasive meningococcal
disease for 2000 were omitted. There were a total of 162 
notifications for that year, compared with 137 notifications
in 1999. Notifications of N. meningiditis group C accounted
for the majority of the increase.
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